HKEX Stock Code: 01093English|繁體|简体

Highlight - FY2023

Revenue
RMB31,450M, +1.7%
Underlying profit attributable to shareholders
RMB6,275M, +2.8%
Profit attributable to shareholders
RMB5,873M, -3.6%
Basic earnings per share (reported)
RMB49.47 cents, -3.2%
Basic earnings per share (underlying profit)
RMB52.86 cents, +3.2%

Key Products

Finished drugs
Bulk drugs
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.